Product NDC: | 0179-0109 |
Proprietary Name: | VENLAFAXINE HYDROCHLORIDE |
Non Proprietary Name: | VENLAFAXINE HYDROCHLORIDE |
Active Ingredient(s): | 100 mg/1 & nbsp; VENLAFAXINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0179-0109 |
Labeler Name: | KAISER FOUNDATION HOSPITALS |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078301 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120105 |
Package NDC: | 0179-0109-70 |
Package Description: | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0109-70) |
NDC Code | 0179-0109-70 |
Proprietary Name | VENLAFAXINE HYDROCHLORIDE |
Package Description | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0109-70) |
Product NDC | 0179-0109 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | VENLAFAXINE HYDROCHLORIDE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120105 |
Marketing Category Name | ANDA |
Labeler Name | KAISER FOUNDATION HOSPITALS |
Substance Name | VENLAFAXINE HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |